Quel est le prix pour BIOLASE, Inc. (BIOL)

Le prix pour BIOLASE, Inc. (BIOL) est $0.00695

Quelle est la capitalisation boursière pour BIOLASE, Inc. (BIOL)

La capitalisation boursière pour BIOLASE, Inc. (BIOL) est $536.40

Bénéfices de BIOLASE, Inc. (BIOL)

BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.

Année	Bénéfices	Changez
2026 (TTM)	$-16.00M	-22.33%
2023	$-20.60M	-27.78%
2022	$-28.53M	77.25%
2021	$-16.09M	-3.64%
2020	$-16.70M	-6.69%
2019	$-17.90M	-16.57%
2018	$-21.45M	23.06%
2017	$-17.43M	14.54%
2016	$-15.22M	-24.28%
2015	$-20.10M	6.84%
2014	$-18.81M	61.55%
2013	$-11.65M	295.45%
2012	$-2.95M	-33.02%
2011	$-4.40M	-63.25%
2010	$-11.96M	321.68%
2009	$-2.84M	-68.51%
2008	$-9.01M	26.57%
2007	$-7.12M	57.21%
2006	$-4.53M	-73.74%
2005	$-17.24M	95.90%
2004	$-8.80M	-214.79%
2003	$7.67M	179.10%
2002	$2.75M	-1,063.86%
2001	$-285.00K	0.00%
2000	0.00	0.00%

Année

Bénéfices

Changez

2026 (TTM)

$-16.00M

-22.33%

2023

$-20.60M

-27.78%

2022

$-28.53M

77.25%

2021

$-16.09M

-3.64%

2020

$-16.70M

-6.69%

2019

$-17.90M

-16.57%

2018

$-21.45M

23.06%

2017

$-17.43M

14.54%

2016

$-15.22M

-24.28%

2015

$-20.10M

6.84%

2014

$-18.81M

61.55%

2013

$-11.65M

295.45%

2012

$-2.95M

-33.02%

2011

$-4.40M

-63.25%

2010

$-11.96M

321.68%

2009

$-2.84M

-68.51%

2008

$-9.01M

26.57%

2007

$-7.12M

57.21%

2006

$-4.53M

-73.74%

2005

$-17.24M

95.90%

2004

$-8.80M

-214.79%

2003

$7.67M

179.10%

2002

$2.75M

-1,063.86%

2001

$-285.00K

0.00%

2000

0.00

0.00%

Entreprise	Bénéfices	Différence de bénéfices	Pays
Abbott Laboratories ABT.US	$7.51B	-47,040.82%	US
Stryker Corporation SYK.US	$5.15B	-32,272.99%	US
Medtronic plc MDT.US	$5.56B	-34,866.58%	IE
Boston Scientific Corporation BSX.US	$3.86B	-24,229.74%	US
Edwards Lifesciences Corporation EW.US	$1.42B	-8,959.45%	US

Entreprise

Bénéfices

Différence de bénéfices

Pays